From Idea to Exit. By Design.
We Build What Buyers Want.

We invest across key inflection points—clinical, regulatory, and commercial—guiding companies through each stage with precision. Our access is different: proprietary deal flow unlocked through board seats, operator ties, and strategic partnerships. We build with the exit in mind from day one, aligning company roadmaps with acquirer priorities. And with an early focus on AI and robotics, we back technologies that are already reshaping care – improving precision, efficiency, and outcomes.